Christopher Krawtschuk serves as Executive at bluebird bio, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Krawtschuk has executed 2 insider transactions totaling $20.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 6, 2023 involved selling 4,526 shares valued at $20.5K.
Christopher Krawtschuk currently holds 45,474 shares of bluebird bio, Inc. (BLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Krawtschuk has been a net seller of BLUE stock. They have purchased $0 and sold $20.5K worth of shares.
Christopher Krawtschuk's most recent insider trade was on Dec 6, 2023, when they sold 4,526 shares at $4.52 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |